Clinical Trials on HER2 Low Breast Carcinoma
Total 2356 results
-
Guangdong Provincial People's HospitalUnknownHER2-Positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownHER2-positive Breast Cancer
-
Shandong UniversityUnknownHER2-positive Breast Cancer
-
Jonsson Comprehensive Cancer CenterNovartis; Seagen Inc.RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
University of WashingtonMerck Sharp & Dohme LLCWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor NegativeUnited States
-
Samsung Medical CenterRecruitingHER2-positive Breast CancerKorea, Republic of
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Latin American Cooperative Oncology GroupRoche Pharma AG; OncoclínicasNot yet recruitingBreast Cancer | HER2-positive Breast CancerBrazil
-
Huashan HospitalRecruitingHER2-positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Fudan UniversityNot yet recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingHER2-positive Breast Cancer
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Hunan Cancer HospitalRecruiting
-
University Health Network, TorontoRecruitingBreast Cancer | HER2-positive Breast CancerCanada
-
German Breast GroupRoche Pharma AGRecruitingHER2-positive Breast CancerGermany
-
iOMEDICO AGSeagen Inc.RecruitingHER2-positive Breast CancerGermany, Austria
-
Xijing HospitalNot yet recruitingBreast Cancer | HER2-positive Breast Cancer
-
Breast Cancer Trials, Australia and New ZealandRecruitingBreast Cancer | HER2-positive Breast CancerAustralia
-
University of UtahRecruitingHER2-negative Breast CancerUnited States
-
Fudan UniversityRecruitingHER2-positive Breast CancerChina
-
Genor Biopharma Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHER2-positive Breast CancerChina
-
New Mexico Cancer Care AllianceRecruitingHER2 Negative Breast CancerUnited States
-
Centre Jean PerrinRecruitingHER2 Positive Breast CancerFrance
-
Shanghai Henlius BiotechActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast CancerChina
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
University of Kansas Medical CenterTerminatedHER2-positive Breast CancerUnited States
-
University of RochesterSuspendedHER2-positive Breast CancerUnited States
-
Armando GiulianoWithdrawnBreast Cancer | HER2-positive Breast CancerUnited States
-
Puma Biotechnology, Inc.CompletedHER2 Amplified Breast CancerPortugal
-
Institut Claudius RegaudTerminated
-
Dorte NielsenTerminated
-
Cancer Institute and Hospital, Chinese Academy...First Affiliated Hospital Xi'an Jiaotong University; Wuhan Union Hospital,... and other collaboratorsUnknownHER2-negative Breast CancerChina
-
Seagen Inc.ParexelApproved for marketing
-
Henan Cancer HospitalUnknown
-
Hebei Medical University Fourth HospitalUnknown
-
Western Regional Medical CenterTerminated
-
Merrimack PharmaceuticalsTerminatedBreast Cancer | HER2 Positive Breast CancerSpain, United States, Italy, France, Canada, Belgium, Austria, Germany, Czech Republic
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterZymeworks BC Inc.Active, not recruitingBreast Cancer | HER2-positiveUnited States
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruitingBreast Cancer | HER2 PositiveNetherlands
-
Eisai Inc.Completed
-
The Netherlands Cancer InstituteCompletedBreast Cancer | HER2 PositiveNetherlands
-
UNICANCERNational Cancer Institute, FranceRecruitingBreast Cancer | DCIS | Low Risk DCIS | Breast Conserving Surgery | Radiotherapy OmissionFrance
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
AstraZenecaCompleted